ValuentumAd

Official PayPal Seal
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Sep 17, 2014
Microsoft Just Hiked Its Dividend 11%!
But you were expecting that.
Sep 15, 2014
Best Ideas Newsletter Excerpt: A+ for Altria and Apple
The intro to the September Best Ideas Newsletter has been released.
Sep 1, 2014
This Firm Just Registered a 10 on the Valuentum Buying Index
This firm's new treatment has a high rate of effectiveness, and its lack of competition has fueled rapid adoption in the medical community. This firm has so much monopolistic power that Congress is complaining that it is putting too much budgetary pressure on Medicare and Medicaid. The company just registered the highest rating of a 10 on the Valuentum Buying Index (equivalent to a "we'd consider buying" rating), and we think there is considerable share-price upside. The stock not only trades at a material discount to its discounted cash-flow-derived intrinsic value, but its earnings multiple is but a fraction of its peer group's.
Aug 26, 2014
Price Is Almost Always Different Than Value
This key tenet behind stock market investing success is worth remembering.
Aug 21, 2014
We Could Have Done Better with Hewlett-Packard
We could have done a better job pounding the table on shares in early 2013.
Aug 21, 2014
Financial Analysis 501: Understanding Cash-Burn Scenarios
Let use J.C. Penney as a case study to learn how to perform cash-burn analysis.
Aug 9, 2014
Energy Transfer Partners’ Solid Distribution Coverage Ratio
Energy Transfer Partners’ distribution is on solid ground, but investors should be aware of the risks of MLPs. Let’s walk through a quick reminder.
Aug 5, 2014
Big Oil Round Up: Earnings Portal
Let’s put together the calendar second-quarter reports from the oil & gas majors.
Jul 30, 2014
Big Pharma Round Up
Let’s take a look at recent quarterly results from Big Pharma.
Jul 25, 2014
Baidu Continues to Impress
Best Ideas portfolio holding Baidu put up impressive second-quarter results. Shares have surged to our fair value estimate.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.